Biostatisticians expect the applicable machine learning, artificial intelligence, or statistical algorithm to change when the target set of cancers for early detection is restricted, or the evaluation ...

Johan Löf, founder and CEO, RaySearch: "I am very much looking forward to meeting both existing and new customers at RSNA and presenting the exciting research results regarding liver ablation and our ...